ABVC BioPharma, Inc. Proceeds from (Repayments of) Bank Overdrafts
ABVC BioPharma, Inc. (ABVC) reported Proceeds from (Repayments of) Bank Overdrafts of -$1.01 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfBankOverdrafts · last filed 2021-03-16
- ABVC BioPharma, Inc. proceeds from (repayments of) bank overdrafts for fiscal 2020 was -$1.01M.
- ABVC BioPharma, Inc. proceeds from (repayments of) bank overdrafts for fiscal 2019 was -$41.59K.
| Period end | Proceeds from (Repayments of) Bank Overdrafts 12 month |
|---|---|
| 2020-12-31 | -$1.01M 10-K · filed 2021-03-16 |
| 2019-12-31 | -$41.59K 10-K · filed 2021-03-16 |